Dalong Qian

11.4k total citations · 5 hit papers
30 papers, 5.4k citations indexed

About

Dalong Qian is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Dalong Qian has authored 30 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 7 papers in Genetics. Recurrent topics in Dalong Qian's work include Cancer Cells and Metastasis (15 papers), MicroRNA in disease regulation (5 papers) and Virus-based gene therapy research (4 papers). Dalong Qian is often cited by papers focused on Cancer Cells and Metastasis (15 papers), MicroRNA in disease regulation (5 papers) and Virus-based gene therapy research (4 papers). Dalong Qian collaborates with scholars based in United States, India and Netherlands. Dalong Qian's co-authors include Michael F. Clarke, Neethan A. Lobo, Yohei Shimono, Michael W. Becker, Irving L. Weissman, Mark J. Kiel, Sean J. Morrison, In-Kyung Park, Maider Zabala and Frederick M. Dirbas and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Dalong Qian

29 papers receiving 5.3k citations

Hit Papers

Bmi-1 is required for maintenance of adult self-renewing ... 2003 2026 2010 2018 2003 2009 2007 2020 2016 400 800 1.2k

Peers

Dalong Qian
John P. Morris United States
David O. Ferguson United States
Ross A. Dickins Australia
Gerald Wulf Germany
Dennis K. Watson United States
John P. Morris United States
Dalong Qian
Citations per year, relative to Dalong Qian Dalong Qian (= 1×) peers John P. Morris

Countries citing papers authored by Dalong Qian

Since Specialization
Citations

This map shows the geographic impact of Dalong Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalong Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalong Qian more than expected).

Fields of papers citing papers by Dalong Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalong Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalong Qian. The network helps show where Dalong Qian may publish in the future.

Co-authorship network of co-authors of Dalong Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Dalong Qian. A scholar is included among the top collaborators of Dalong Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalong Qian. Dalong Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yong, et al.. (2025). Research progress and clinical application of all-inside reconstruction techniques: narrative review. Frontiers in Surgery. 12. 1644737–1644737.
2.
Sikandar, Shaheen S., Gunsagar S. Gulati, Jane Antony, et al.. (2022). Identification of a minority population of LMO2 + breast cancer cells that integrate into the vasculature and initiate metastasis. Science Advances. 8(45). eabm3548–eabm3548. 3 indexed citations
3.
Reinitz, Felicia, Benedetta Nicolis di Robilant, Bayarsaikhan Chuluun, et al.. (2022). Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model. eLife. 11. 9 indexed citations
4.
Hisamori, Shigeo, Sanjay Koul, Takanori Hayashi, et al.. (2022). Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells. Journal of Gastroenterology. 57(6). 407–422. 5 indexed citations
5.
Weele, Linda J. van, Sabra Djomehri, Shang Cai, et al.. (2022). Mesenchymal tumor cells drive adaptive resistance of Trp53−/− breast tumor cells to inactivated mutant Kras. Molecular Oncology. 16(17). 3128–3145. 1 indexed citations
6.
Zabala, Maider, Neethan A. Lobo, Jane Antony, et al.. (2020). LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis. Cell stem cell. 27(2). 284–299.e8. 12 indexed citations
7.
Gulati, Gunsagar S., Shaheen S. Sikandar, Daniel J. Wesche, et al.. (2020). Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 367(6476). 405–411. 712 indexed citations breakdown →
8.
Lobo, Neethan A., Maider Zabala, Dalong Qian, & Michael F. Clarke. (2018). Serially transplantable mammary epithelial cells express the Thy-1 antigen. Breast Cancer Research. 20(1). 121–121. 4 indexed citations
9.
Sikandar, Shaheen S., Angera H. Kuo, Tomer Kalisky, et al.. (2017). Role of epithelial to mesenchymal transition associated genes in mammary gland regeneration and breast tumorigenesis. Nature Communications. 8(1). 1669–1669. 45 indexed citations
10.
Dalerba, Piero, Debashis Sahoo, Soonmyung Paik, et al.. (2016). CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. New England Journal of Medicine. 374(3). 211–222. 330 indexed citations breakdown →
11.
Isobe, Taichi, Shigeo Hisamori, Daniel J. Hogan, et al.. (2014). miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. eLife. 3. 155 indexed citations
12.
Scheeren, Ferenc A., Angera H. Kuo, Linda J. van Weele, et al.. (2014). A cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesis. Nature Cell Biology. 16(12). 1238–1248. 97 indexed citations
13.
Adorno, Maddalena, Shaheen S. Sikandar, Siddhartha S. Mitra, et al.. (2013). Usp16 contributes to somatic stem-cell defects in Down’s syndrome. Nature. 501(7467). 380–384. 98 indexed citations
14.
Shimono, Yohei, Maider Zabala, Robert W. Cho, et al.. (2009). Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells. Cell. 138(3). 592–603. 971 indexed citations breakdown →
15.
Park, Inkyung, et al.. (2008). Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors. Nature. 453(7192). 228–232. 131 indexed citations
16.
Park, In-Kyung, Dalong Qian, Mark J. Kiel, et al.. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423(6937). 302–305. 1456 indexed citations breakdown →
17.
Morrison, Sean J., Dalong Qian, Libuse Jerabek, et al.. (2002). A Genetic Determinant That Specifically Regulates the Frequency of Hematopoietic Stem Cells. The Journal of Immunology. 168(2). 635–642. 80 indexed citations
18.
Mitra, Raj S., Mary Benedict, Dalong Qian, et al.. (2001). Killing of Sarcoma Cells by Proapoptotic Bcl-XS: Role of the BH3 Domain and Regulation by Bcl-XL. Neoplasia. 3(5). 437–445. 10 indexed citations
19.
Han, Jeffrey S., Dalong Qian, Max S. Wicha, & Michael F. Clarke. (1998). A Method of Limited Replication for the Efficient In Vivo Delivery of Adenovirus to Cancer Cells. Human Gene Therapy. 9(8). 1209–1216. 15 indexed citations
20.
Ewart, H. Stephen, Dalong Qian, & John T. Brosnan. (1995). Activation of Hepatic Glutaminase in the Endotoxin-Treated Rat. Journal of Surgical Research. 59(2). 245–249. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026